Not applicableUnknownNCT03263663
What this trial is testing
Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model
Who this might be right for
Colo-rectal CancerRAS Wild-typeUICC III+2 more
PD Dr. med. Volker Heinemann 1,000